Variations in Tcdb activity and the hypervirulence of emerging strains of clostridium difficile

PLoS Pathogens

Volumn 6, Issue 8, 2010, Pages 65-66

  Lanis, Jordi M ^a   Barua, Soumitra ^a   Ballard, Jimmy D ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; TRYPTOPHAN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRULENCE FACTOR TCDB; BACTERIAL PROTEIN; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

ACIDITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; EMBRYO; ENDOCYTOSIS; FLUORESCENCE ANALYSIS; GENE LOCUS; HYDROPHOBICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY ISLAND; PH; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; ZEBRA FISH; AMINO ACID SEQUENCE; ANIMAL; CELL SEPARATION; CHEMISTRY; CHO CELL; CRICETULUS; FLOW CYTOMETRY; GENETICS; HAMSTER; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; PROTEIN CONFORMATION;

CLOSTRIDIUM DIFFICILE; DANIO RERIO;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL SEPARATION; CHO CELLS; CLOSTRIDIUM DIFFICILE; CRICETINAE; CRICETULUS; FLOW CYTOMETRY; HYDROGEN-ION CONCENTRATION; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; VIRULENCE FACTORS; ZEBRAFISH;

EID: 77958132074     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001061     Document Type: Article

References (50)

1. Hall IC, O'Toole E (1935) Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 49: 390-402.
2. George RH, Symonds JM, Dimock F, Brown JD, Arabi Y, et al. (1978) Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J 1: 695.
3. Chang TW, Bartlett JG, Gorbach SL, Onderdonk AB (1978) Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun 20: 526-529.
4. Bartlett JG (1992) Antibiotic-associated diarrhea. Clin Infect Dis 15: 9.
5. Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, et al. (2005) A Large Outbreak of Clostridium difficile-Associated Disease With an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use. Infection Control and Hospital Epidemiology 26: 273-280.
6. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, et al. (2005) A Predominantly Clonal Multi-Institutional Outbreak of Clostridium difficile-Associated Diarrhea with High Morbidity and Mortality. N Engl J Med 353: 2442-2449.
7. McDonald LC, Killgore GE, Thompson A, Owens RC, Jr., Kazakova SV, et al. (2005) An Epidemic, Toxin Gene-Variant Strain of Clostridium difficile. N Engl J Med 353: 2433-2441.
8. Warny M, Pepin J, Fang A, Killgore G, Thompson A, et al. (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. The Lancet 366: 1079-1084.
9. Akerlund T, Persson I, Unemo M, Noren T, Svenungsson B, et al. (2008) Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol 46: 1530-1533.
10. MacCannell DR, Louie TJ, Gregson DB, Laverdiere M, Labbe A-C, et al. (2006) Molecular Analysis of Clostridium difficile PCR Ribotype 027 Isolates from Eastern and Western Canada. J Clin Microbiol 44: 2147-2152.
11. Geric B, Rupnik M, Gerding DN, Grabnar M, Johnson S (2004) Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 53: 887-894.
12. Goncalves C, Decre D, Barbut F, Burghoffer B, Petit J-C (2004) Prevalence and Characterization of a Binary Toxin (Actin-Specific ADP-Ribosyltransferase) from Clostridium difficile. J Clin Microbiol 42: 1933-1939.
13. Schwan C, Stecher Br, Tzivelekidis T, van Ham M, Rohde M, et al. (2009) Clostridium difficile Toxin CDT Induces Formation of Microtubule-Based Protrusions and Increases Adherence of Bacteria. PLoS Pathog 5: e1000626.
14. Bourgault A-M, Lamothe F, Loo VG, Poirier L, the CDAD-CSI Study Group (2006) In Vitro Susceptibility of Clostridium difficile Clinical Isolates from a Multi-Institutional Outbreak in Southern Quebec, Canada. Antimicrob Agents Chemother 50: 3473-3475.
15. Drudy D, Quinn T, O'Mahony R, Kyne L, O'Gaora P, et al. (2006) High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile. J Antimicrob Chemother 58: 1264-1267.
16. Drudy D, Kyne L, ROM S, Fanning (2007) gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerg Infect Dis 13: 2.
17. Stabler R, He M, Dawson L, Martin M, Valiente E, et al. (2009) Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biology 10: R102.
18. Tan KS, Wee BY, Song KP (2001) Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile. J Med Microbiol 50: 613-619.
19. Hammond GA, Johnson JL (1995) The toxigenic element of Clostridium difficile strain VPI 10463. Microbial Pathogenesis 19: 203-213.
20. Just I, Selzer J, Wilm M, Eichel-Streiber CV, Mann M, et al. (1995) Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375: 500-503.
21. Eichel-Streiber CV, Dagmar Meyer ZU Heringdorf EH, Sabine Sartingen (1995) Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B. Mol Microbiol 17: 313-321.
22. Faust C, Ye B, Song K-P (1998) The Enzymatic Domain of Clostridium difficile Toxin A Is Located within Its N-Terminal Region. Biochemical and Biophysical Research Communications 251: 100-105.
23. Hofmann F, Busch C, Prepens U, Just I, Aktories K (1997) Localization of the Glucosyltransferase Activity of Clostridium difficile Toxin B to the N-terminal Part of the Holotoxin. J Biol Chem 272: 11074-11078.
24. Busch C, Hofmann F, SelzerJr, Munro S, Jeckel D, et al. (1998) A Common Motif of Eukaryotic Glycosyltransferases Is Essential for the Enzyme Activity of Large Clostridial Cytotoxins. J Biol Chem 273: 19566-19572.
25. Busch C, Hofmann F, Gerhard R, Aktories K (2000) Involvement of a Conserved Tryptophan Residue in the UDP-Glucose Binding of Large Clostridial Cytotoxin Glycosyltransferases. J Biol Chem 275: 13228-13234.
26. Hofmann F, Busch C, Aktories K (1998) Chimeric Clostridial Cytotoxins: Identification of the N-Terminal Region Involved in Protein Substrate Recognition. Infect Immun 66: 1076-1081.
27. Rupnik M, Pabst S, Rupnik M, von Eichel-Streiber C, Urlaub H, et al. (2005) Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology 151: 199-208.
28. Reineke J, Tenzer S, Rupnik M, Koschinski A, Hasselmayer O, et al. (2007) Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446: 415-419.
29. Egerer M, Giesemann T, Jank T, Satchell KJF, Aktories K (2007) Auto-catalytic Cleavage of Clostridium difficile Toxins A and B Depends on Cysteine Protease Activity. J Biol Chem 282: 25314-25321.
30. Dingle T, Wee S, Mulvey GL, Greco A, Kitova EN, et al. (2008) Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile. Glycobiology 18: 698-706.
31. Wren BW (1991) A family of clostridial and streptococcal ligand-binding proteins with conserved C-terminal repeat sequences. Mol Microbiol 5: 797-803.
32. Eichel-Streiber C, Laufenberg-Feldmann R, Sartingen S, Schulze J, Sauerborn M (1992) Comparative sequence analysis of the Clostridium difficile toxins A and B. Molecular and General Genetics 233: 260-268.
33. von Eichel-Streiber C, Sauerborn M (1990) Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. Gene 96: 107-113.
34. Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS, et al. (2006) Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol 188: 7297-7305.
35. von Eichel-Streiber C, Sauerborn M, Kuramitsu HK (1992) Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate- binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases. J Bacteriol 174: 6707-6710.
36. Albesa-JovE D, Bertrand T, Carpenter EP, Swain GV, Lim J, et al. Four Distinct Structural Domains in Clostridium difficile Toxin B Visualized Using SAXS. Journal of Molecular Biology 396: 1260-1270.
37. Hamm EE, Voth DE, Ballard JD (2006) Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication. Proc Natl Acad Sci U S A 103: 14176-14181.
38. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, et al. (1998) HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 95: 2979-2984.
39. Ballard JD, Collier RJ, Starnbach MN (1996) Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo. Proc Natl Acad Sci U S A 93: 12531-12534.
40. Spyres LM, Qa'Dan M, Meader A, Tomasek JJ, Howard EW, et al. (2001) Cytosolic Delivery and Characterization of the TcdB Glucosylating Domain by Using a Heterologous Protein Fusion. Infect Immun 69: 599-601.
41. Qa'Dan M, Spyres LM, Ballard JD (2000) pH-Induced Conformational Changes in Clostridium difficile Toxin B. Infect Immun 68: 2470-2474.
42. Barth H, Pfeifer G, Hofmann F, Maier E, Benz R, et al. (2001) Low pH-induced Formation of Ion Channels by Clostridium difficile Toxin B in Target Cells. J Biol Chem 276: 10670-10676.
43. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, et al. (2009) Toxin B is essential for virulence of Clostridium difficile. Nature 458: 1176-1179.
44. Razaq N, Sambol S, Nagaro K, Zukowski W, Cheknis A, et al. (2007) Infection of Hamsters with Historical and Epidemic BI Types of Clostridium difficile. J Infect Dis 196: 1813-1819.
45. Rupnik M, Grabnar M, Geric B (2003) Binary toxin producing Clostridium difficile strains. Anaerobe 9: 289-294.
46. Barbut F, Decre D, Lalande V, Burghoffer B, Noussair L, et al. (2005) Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54: 181-185.
47. Geric B, Carman RJ, Rupnik M, Genheimer CW, Sambol SP, et al. (2006) Binary Toxin Producing, Large Clostridial Toxin Negative Clostridium difficile Strains Are Enterotoxic but Do Not Cause Disease in Hamsters. J Infect Dis 193: 1143-1150.
48. Murray R, Boyd D, Levett P, Mulvey M, Alfa M (2009) Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infectious Diseases 9: 103.
49. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, et al. (2010) Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A: 107: 7527-7532.
50. Voth DE, Hamm EE, Nguyen LG, Tucker AE, Salles II, et al. (2005) Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell Microbiol 7: 1139-1149.